Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
51.7%
% of FTXH's 30 holdings also in PJP
65.2%
% of PJP's 23 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 7.8% | 6.4% | 6.4% |
|
GILEAD SCIENCES INC | 7.6% | 6.4% | 6.4% |
|
JOHNSON & JOHNSON | 7.6% | 6.1% | 6.1% |
|
AMGEN INC | 7.2% | 5.6% | 5.6% |
|
ABBVIE INC | 3.7% | 6.0% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PJP
|
BRISTOL-MYERS SQUIBB CO | 7.3% |
|
ORGANON & CO. | 4.7% |
|
VIATRIS, INC. | 4.4% |
|
CARDINAL HEALTH INC | 3.9% |
|
IRONWOOD PHARMACEUTICALS INC | 3.9% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
 |
ALKERMES PLC | 2.0% |
|
BIOMARIN PHARMACEUTICAL INC | 2.0% |
|
SEATTLE GENETICS INC | 2.0% |
|
ELANCO ANIMAL HEALTH, INC. | 1.9% |
FTXH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -6.7% |
|
ELI LILLY & CO | -4.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.9% |
|
AMPHASTAR PHARMACEUTICALS INC | -3.5% |
|
TRAVERE THERAPEUTICS, INC. | -3.5% |
|
REGENERON PHARMACEUTICALS | -3.3% |
|
BIOGEN IDEC INC | -3.1% |
|
LIGAND PHARMACEUTICALS-CL B | -3.0% |
|
HORIZON PHARMA PLC | -2.8% |
 |
VALEANT PHARMACEUTICALS INT'L | -2.7% |